IDXX
IDEXX LABORATORIES INC /DEC5615-min delayed · EOD close535.38 +1.15% upas of 2026-09-04mkt cap $42.2B
In Vitro & In Vivo Diagnostic Substances · SIC 2835 · CIK 0000874716
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $4.6B | 2026-06-30 | 10-Q · 0000874716-26-000123 |
| Revenue (prior year) | $3.9B | 2024-12-31 | 10-K · 0000874716-25-000037 |
| Gross profit | $2.8B | 2026-06-30 | 10-Q · 0000874716-26-000123 |
| Operating income | $1.5B | 2026-06-30 | 10-Q · 0000874716-26-000123 |
| Net income | $1.1B | 2026-06-30 | 10-Q · 0000874716-26-000123 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $3.4B | 2026-06-30 | 10-Q · 0000874716-26-000123 |
| Current assets | $1.5B | 2026-06-30 | 10-Q · 0000874716-26-000123 |